On Tuesday, Genelux Corp (NASDAQ: GNLX) was 17.48% up from the session before settling in for the closing price of $2.46. A 52-week range for GNLX has been $1.60 – $13.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -24.62% over the past five years. When this article was written, the company’s average yearly earnings per share was at 23.62%. With a float of $30.04 million, this company’s outstanding shares have now reached $34.54 million.
Let’s look at the performance matrix of the company that is accounted for 23 employees. In terms of profitability, gross margin is 55.64%, operating margin of -1966.64%, and the pretax margin is -1879.08%.
Genelux Corp (GNLX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Genelux Corp stocks. The insider ownership of Genelux Corp is 13.03%, while institutional ownership is 15.11%. The most recent insider transaction that took place on Dec 30 ’24, was worth 8,512. In this transaction Director of this company sold 3,460 shares at a rate of $2.46, taking the stock ownership to the 45,791 shares. Before that another transaction happened on Dec 30 ’24, when Company’s Director proposed sale 3,460 for $2.46, making the entire transaction worth $8,512.
Genelux Corp (GNLX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.62% per share during the next fiscal year.
Genelux Corp (NASDAQ: GNLX) Trading Performance Indicators
You can see what Genelux Corp (GNLX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.47. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9981.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.95, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of Genelux Corp (GNLX)
Genelux Corp (NASDAQ: GNLX) saw its 5-day average volume 0.32 million, a positive change from its year-to-date volume of 0.18 million. As of the previous 9 days, the stock’s Stochastic %D was 45.84%. Additionally, its Average True Range was 0.25.
During the past 100 days, Genelux Corp’s (GNLX) raw stochastic average was set at 56.97%, which indicates a significant increase from 55.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.84% in the past 14 days, which was lower than the 94.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.58, while its 200-day Moving Average is $2.70. Nevertheless, the first resistance level for the watch stands at $3.30 in the near term. At $3.71, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.01. If the price goes on to break the first support level at $2.59, it is likely to go to the next support level at $2.29. The third support level lies at $1.88 if the price breaches the second support level.
Genelux Corp (NASDAQ: GNLX) Key Stats
There are 34,538K outstanding shares of the company, which has a market capitalization of 99.81 million. As of now, sales total 170 K while income totals -28,300 K. Its latest quarter income was 0 K while its last quarter net income were -6,580 K.
